These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice. Larson K; Damon M; Randhi R; Nixon-Lee N; J Dixon K CNS Neurol Disord Drug Targets; 2022 Jun; ():. PubMed ID: 35692164 [TBL] [Abstract][Full Text] [Related]
13. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369 [TBL] [Abstract][Full Text] [Related]
14. XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn. Zhou KX; He XT; Hu XF; Zhao WJ; Li CX; Zhang C; Zhang T; Gu ZX; Deng JP; Dong YL Brain Res Bull; 2019 Jul; 149():137-147. PubMed ID: 31002915 [TBL] [Abstract][Full Text] [Related]